WHO ICTRP trial
Evaluation of the effect of probiotic supplementation on the proteinuria
IRCT20190415043279N11 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20190415043279N11 |
|---|---|
| Public title | Evaluation of the effect of probiotic supplementation on the proteinuria |
| Scientific title | Evaluation of the effect of probiotic supplementation on the improvement of proteinuria in patients with immunoglobulin A nephropathy |
| Primary sponsor | Sanandaj University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | IgA nephropathy. Diabetes mellitus due to underlying condition with diabetic nephropathy;E08.21 |
| Interventions | Intervention 1: Intervention group: Omega 3 capsules 1000 mg and Valsartan in addition to probiotic capsules of Milad Pouya Company Probiotic Capsules, approved by the US Food and Drug Administration and under the brand name Prodigest, are… |
| Registration date | Mar 7, 2022 |
| Target size | 120 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: